Product: | Famotidine-13C3 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number: | C10205 | ||||||||
Synonyms: | 3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]-N-(aminosulfonyl)propanimidamide-13C3 | ||||||||
Pricing: |
|
||||||||
Formula: | C513C3H15N7O2S3 | ||||||||
Enrichment: | 99% 13C | ||||||||
Chemical Purity: | 98% | ||||||||
Molecular Weight: | 340.43 | ||||||||
Structure: | |||||||||
Category: | Research Compounds | ||||||||
Literature References: |
Soga, T; Matsuura, M; Kodama, Y; Fujita, T; Sekimoto, I; Nishimura, K; Yoshida, S; Kutsumi, H; Fujimoto, S., Is a proton pump inhibitor necessary for the treatment of lower-grade reflux esophagitis?. Journal of gastroenterology, 1999, 34 (4): 435–440.; Hu, FL; Jia, JC; Li, YL; Yang, GB, Comparison of H2-receptor antagonist- and proton-pump inhibitor-based triple regimens for the eradication of Helicobacter pylori in Chinese patients with gastritis or peptic ulcer. The Journal of international medical research, 2003, 31 (6): 469–474. |
||||||||
MSDS: | |||||||||
Applications: | A labeled histamine H2-receptor antagonist. Inhibits stomach acid production. Used to treat peptic ulcer disease and gastroesophageal reflux disease. |